Shanafelt, A.B. and Kastelein, R.A. (1992) High affinity ligand binding is not essential
for granulocyte-macrophage colony-stimulating factor receptor activation. J. Biol.
Chem. 267, 25466-25472.
Singh, S.M. and Panda, A.K. (2005) Solubilization and refolding of bacterial inclusion
body proteins. J. Biosci. Bioeng. 99, 303-310.
Smith, H.O., Hutchison, C.A., Pfannkoch, C. and Venter, J.C: (2003) Generating a
synthetic genome by whole genome assembly. φX174 bacteriophage from synthetic
oligonucleotides. Proc. Natl. Acad. Sci. USA. 100, 15440-15445.
Walter, M.R., Cook, W.J., Ealick, S.E., Nagabhushan, T.L., Trotta, P.P. and Bug, C.E.
(1992) Three-dimensional structure of recombinant human granulocyte-macrophage
colony-stimulating factor. J. Mol. Biol. 224, 1075-1085.
Wong, G.G., Witek, J.S., Temple, P.A., Wilkens, K.M., Leary, A.C., Luxenberg, D.P.,
Jones, S.S., Brown, E.L., Kay, R.M. and Orr, E.C. (1985) Human GM-CSF: molecular
cloning of the complementary DNA and purification of the natural and recombinant
proteins. Science 228, 810–815.
Woodcock, J., Griffin, J., Behrman R., Cherney B., Crescenzi T., Fraser B., Hixon D.,
Joneckis, C., Kozlowski, S., Rosenberg A., Schrager, L. Shacter, E., Temple, R.,
Webber, K. and Winkle, H. (2007) The FDA’s assessment of follow-on protein
products: a historical perspective. Nat. Rev. Drug Discov. 6, 437-442.